Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multicentre, open-label study of propranolol in infants with proliferating infantile hemangioma requiring systemic therapy

Trial Profile

A multicentre, open-label study of propranolol in infants with proliferating infantile hemangioma requiring systemic therapy

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Nov 2018

At a glance

  • Drugs Propranolol (Primary)
  • Indications Haemangioma
  • Focus Adverse reactions
  • Sponsors Pierre Fabre
  • Most Recent Events

    • 07 Nov 2018 Status changed to completed.
    • 05 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top